September 23, 2017
VIMPAT Receives EU Approval for Expanded Pediatric Use
News
The European Commission has approved the expansion of the use of UCB’s VIMPAT (lacosamide) to include monotherapy and adjunctive therapy of partial-onset ... Read more
July 24, 2017
Pairnomix, StemoniX Develop Epilepsy Model in Search for New Anti-seizure Drugs
News
Pairnomix has joined efforts with StemoniX to develop a lab-based model of epileptic seizures using so-called induced pluripotent stem cells ... Read more
July 21, 2017July 21, 2017
Data Lacking to Explain Why US Doctors Prefer Keppra to Treat Pediatric Epilepsy, Researchers Say
News
Doctors have several anti-seizure options to treat epilepsy, but little data exists to show which of these treatments is ... Read more
July 19, 2017July 19, 2017
EU Regulators to Hold Public Hearing on Valproate Therapies’ Effect on Pregnant Women
News
The European Medicines Agency has scheduled an unprecedented public hearing in September on whether epilepsy therapies that contain sodium valproate pose a risk to ... Read more
July 17, 2017
MRI-Guided Laser Technique May Be Potential Surgery Treatment for Certain Epilepsy Patients, Review Says
News
A technique called MRI-guided laser interstitial thermal therapy (MgLiTT) may be a potential treatment for epilepsy patients, according to ... Read more
July 14, 2017
Cleveland Clinic Researcher Wins $3.4 Million Grant to Develop Better Predictor of Epileptic Surgery Outcomes
News
The National Institutes of Health has awarded a $3.4 million grant to a Cleveland Clinic-led research collaboration whose objective is to ... Read more
July 12, 2017July 17, 2017
Surgery in Older Patients with Drug-resistant Focal Epilepsy Still Effective, Study Finds
News
Researchers studied the medical records of patients with drug-resistant focal epilepsy who underwent surgery for the disorder at the age ... Read more
July 10, 2017July 10, 2017
Ultra-Marathon Cyclist Who Is Epileptic Breaks Two World Indoor Distance Records
News
An ultra-marathon cyclist with epilepsy has broken world indoor-track records for the longest distances covered in six and eight hours. ... Read more
July 5, 2017
LivaNova’s VNS Therapy for Medication-Resistant Epilepsy Approved for Young Children
News
The U.S. Food and Drug Administration (FDA) recently approved LivaNova’s VNS Therapy Systems for the treatment of drug-resistant partial ... Read more
June 30, 2017June 30, 2017
Zebinix/Aptiom Does Not Reduce Cognition in Epileptic Children, Phase 2 Clinical Trial Indicates
News
The epilepsy therapy known as Zebinix in Europe and Aptiom in the United States does not impair cognition in ... Read more
June 28, 2017June 28, 2017
Nearly Half of Epileptics Forget to Take Their Meds at Least Once a Month, Poll Shows
News
Almost half of epilepsy patients surveyed in a British poll say they’ve forgotten to take their medications at least ... Read more
June 26, 2017June 26, 2017
LivaNova’s VNS Therapy Systems Approved for Use with MRI Brain Scans
News
The U.S. Food and Drug Administration has granted expanded approval to LivaNova’s VNS Therapy Systems for people with drug-resistant epilepsy that ... Read more

May 24, 2017

Herantis Granted US Patent for Therapeutic Use of MANF for Epilepsy, Other Neurological Diseases

News

Herantis Pharma was granted a patent by the U.S. Patent and Trademark Office (USPTO) for the use of MANF (mesencephalic astrocyte-derived neurotrophic factor) in the treatment of neurological diseases like ... Read more

May 22, 2017May 22, 2017

Epilepsy Seizure Treatment Trobalt to Be Discontinued in June 2017

News

GlaxoSmithkline (GSK) announced that its epilepsy seizure drug Trobalt (retigabine) will no longer be commercially available after June 2017. The company has advised healthcare providers to seek alternative medicines ... Read more

May 19, 2017May 19, 2017

Possible Link Between Type of Brain Cells and Absence Epilepsy Is Subject of Study

News

A grant from Epilepsy Research UK will allow researchers to study a specific type of brain cells in hopes of identifying a new therapeutic target to treat absence epilepsy, a form of ... Read more

May 17, 2017

Protein Found That May Improve Epilepsy Patients’ Response to Therapies

News

A protein that may help epilepsy patients respond better to drug therapies has been identified, a new study suggests. The study, titled “Molecular isoforms of high-mobility group box 1 ... Read more

May 15, 2017May 15, 2017

Stem Cell Therapy Shows Potential in Treating Medication-resistant Epilepsy Patients

News

Stem cell therapy may be a safe and promising treatment option for epilepsy patients who are resistant to antiepileptic drugs, according to new research. The study, “Treatment of refractory ... Read more

May 12, 2017

Stimulation of Brain Regulatory System Improves Seizures, Guinea Pig Study Shows

News

Stimulation of the endocannabinoid system — a natural regulator in the brain that modulates the release of agents that excite or inhibit central nervous system activity — prompts beneficial ... Read more

May 10, 2017May 10, 2017

Clinical Trial to Assess Vigabatrin for Preventing or Delaying Seizures in Children with Tuberous Sclerosis

News

Texas-led researchers are recruiting children for a Phase 2b clinical trial that will investigate whether vigabatrin can prevent or delay the onset of epileptic seizures in youngsters with tuberous ... Read more

May 8, 2017May 9, 2017

Investigational Epilepsy Therapy for Children Shows Targeted Potential in Early Testing

News

Preclinical studies on The Cell Factory’s lead investigational biologic drug (CF-MEV-117) for the treatment of drug-resistant epilepsy in children has been shown to have dose-dependent anti-inflammatory and immunosuppressive activity. ... Read more

May 5, 2017May 5, 2017

Anxiety, Depression More Prevalent Among Epileptics, Study Finds

News

Epileptics frequently suffer from anxiety and depression, but experts aren’t completely sure why, according to a recent study. The study, “Anxiety and Depressive Disorders in People with Epilepsy: A ... Read more

May 3, 2017

Zogenix Completes Enrollment for Phase 3 Trial of ZX008 as Dravet Syndrome Therapy

News

Zogenix has completed patient enrollment for the Phase 3 Study 1 trial (NCT02826863) of ZX008 as an add-on therapy for seizures in children and young adults with Dravet syndrome. ... Read more

April 28, 2017May 4, 2017

Fycompa Effective as Add-on Antiepileptic Drug in Patients with Tonic-Clonic Seizures, Data Suggests

News

Eisai recently presented data in Boston showing that the effect of its epilepsy treatment, Fycompa, and other antiepileptic drugs (AEDs) against primary generalized tonic-clonic seizures seems to be similarly positive in children and adults. ... Read more

April 26, 2017

Obesity During Pregnancy Boosts Risk of Childhood Epilepsy, Study Finds

News

Maternal obesity may lead to increased rates of childhood epilepsy. That is the finding of researchers in Sweden who conducted the study “Maternal Body Mass Index in Early Pregnancy ... Read more

VIMPAT Receives EU Approval for Expanded Pediatric Use

Pairnomix, StemoniX Develop Epilepsy Model in Search for New Anti-seizure Drugs

Data Lacking to Explain Why US Doctors Prefer Keppra to Treat Pediatric Epilepsy, Researchers Say

EU Regulators to Hold Public Hearing on Valproate Therapies’ Effect on Pregnant Women

MRI-Guided Laser Technique May Be Potential Surgery Treatment for Certain Epilepsy Patients, Review Says

Cleveland Clinic Researcher Wins $3.4 Million Grant to Develop Better Predictor of Epileptic Surgery Outcomes

Surgery in Older Patients with Drug-resistant Focal Epilepsy Still Effective, Study Finds

Ultra-Marathon Cyclist Who Is Epileptic Breaks Two World Indoor Distance Records

LivaNova’s VNS Therapy for Medication-Resistant Epilepsy Approved for Young Children

Zebinix/Aptiom Does Not Reduce Cognition in Epileptic Children, Phase 2 Clinical Trial Indicates

Nearly Half of Epileptics Forget to Take Their Meds at Least Once a Month, Poll Shows

LivaNova’s VNS Therapy Systems Approved for Use with MRI Brain Scans